Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's very encouraging.
Yep. Below six now and headed lower.
I don't know how he voted in that appeal though. I assume he voted against reversal. Do you know?
One from column A, one from column B and one from column C.
Just a reminder that Newman, O'Malley and Reyna sat for the cyclobenzaprine appeal.
If it's laphroaig it's whisky.;^)
Markman proposed that the judges could set aside Du's weighting of secondaries thereby disposing of her unprecedented formulation and still affirm after a denovo review of secondaries. That seems to me to be the most plausible scenario if they do affirm.
"Both IP specialists see roughly 55% chance Amarin can win its appeal, but both also highlighted low odds of reversals in these type of cases...the attorneys think odds of winning the appeal can swing from 0% to 70% depending on the panel make-up."
"Both IP specialists see roughly 55% chance Amarin can win its appeal, but both also highlighted low odds of reversals in these type of cases...the attorneys think odds of winning the appeal can swing from 0% to 70% depending on the panel make-up."$AMRNhttps://t.co/xZ5dd2MfRy
— TerraPharma (@TerraPharma1) September 1, 2020
Wasn't Hikmas case consolidated with the appeal and Reddy's was not. If so, does that change your thinking at all?
Right. Would you say the same about Fu?
Aetna is pocketing the difference?
Does this mean those judges won't be on our panel?
Volume is good and the price is declining steadily but pre market trading has never been a reliable indicator.
Obviousness?
I hope that's allowed under the procedures for an appeals court hearing. There was a discussion some months back on the board about introducing extraordinary new information and IIRC thats possible.
Principal Findings:
The primary outcome, change in low attenuation plaque volume, for icosapent ethyl vs. placebo, was -0.3 vs. 0.9 mm3 (p = 0.006).
Secondary outcomes for icosapent ethyl vs. placebo:
Change in total plaque volume: -9% vs. 11% (p = 0.002)
Change in total noncalcified plaque: -19% vs. 9% (p = 0.0005)
Change in fibrofatty plaque: -34% vs. 32% (p = 0.0002)
Change in triglycerides: -89.3 vs. -92.1 mg/dl (p = 0.91)
The only secondary endpoint which did not achieve a significant difference between groups in multivariable modeling was dense calcium (p=0.053). (So close!)
Sure. I'm celebrating this morning. Awesome results and I think unprecedented. Cheers!
A few questions. First of all, I take it these results are unprecedented. No other drug has ever achieved this result.
As for a label change, wouldn't that require a broader FDA sponsored trial? Or can a label change be approved on the basis of this small trial? As for advertising, that would have to be FDA approved and I wonder if they can even include these results without going through another tortuous approval process.
Looks like it will hold above 7 anyway. Of course, I was being cynical on my post considering how many times the price has magically hit the max pain sweet spot in the past.
$7.00 at the close. Guaranteed.
"If prescribed to every US adult who has known cardiovascular disease or diabetes with well-controlled LDL cholesterol on statin therapy but elevated fasting triglycerides, icosapent ethyl (Vascepa) holds potential to prevent at least 70,000 cardiovascular events annually" $AMRN
"If prescribed to every US adult who has known cardiovascular disease or diabetes with well-controlled LDL cholesterol on statin therapy but elevated fasting triglycerides, icosapent ethyl (Vascepa) holds potential to prevent at least 70,000 cardiovascular events annually" $AMRN https://t.co/fCKLk1eA4W
— TerraPharma (@TerraPharma1) August 27, 2020
It was a joke. Missed the wink at the end did you? I know it's because we got upgraded. Lighten up.
On much better than average volume too. Somebody knows something!;)
On good volume
If Amarin loses and elects to continue the appeal to the SC they still have the ability to file an injunction if generics enter the market. At least I think that's correct and I did drive by a holiday inn express under construction today.
Prescription drug prices are down. At least I'm seeing anecdotal evidence of that. Per Trump's EO drug prices can't exceed the price charged in other countries. Has anyone seen any evidence this is affecting vascepa? The price comparison would have to be with Canada.
When you're young you worry about what people think of you. When you're middle-aged you don't care what people think of you. When you're old you realize people never thought of you.
The stock market doesn't think of us.
Interesting read. Potentially vascepa related
https://medicalxpress.com/news/2020-08-excessive-fructose-consumption-leaky-gut.html
Me too. Posted here in hopes someone familiar with the science can answer that question.
Here's a direct link to the article
https://www.sciencedirect.com/science/article/abs/pii/S1388198120301980?via%3Dihub
Could they conduct an FDA approved trial with a different primary endpoint next so as to be able to make it a part of their label?
Hopefully they hit their primary endpoint at least.
So now the guessing game begins. There will be a lot if speculative buying tomorrow.
Unless this July article is outdated tesla will also build the model Y as well as the model 3 in Texas for east coast delivery and the Semi whenever they roll that out.
https://www.google.com/amp/s/www.theverge.com/platform/amp/2020/7/22/21334860/tesla-cybertruck-factory-austin-texas-location-model-y
Spacex too. They shifted production of the future starship from California to South Texas.
You're living 20 years in the past. The reality today is that those three states are headed for 3rd world status.
Let's find out.
I can't find anything this morning about the FDA approving a new use for rlf100 so I think that news report is referring to the FDA allowing the use of the drug as a compassionate use drug. So, not a big deal.
Thanks. That's a really narrow approved use but if the drug can save lives when there's basically little hope left that would be great.